Deferiprone
Vitamin c
Ain Shams UniversitySmall moleculePhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 89/ 100
Competitive context
1 Active assets in the Vitamin c cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Adebrelimab Fudan University | Phase 3 | B |
Deferasirox Ain Shams University | Phase 2/3 | B |
Same molecule, other indications
Deferiprone is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →